The policy statement of the American academy of pediatrics – children as hematopoietic stem cell donors – a proposal of modifications for application in the UK by unknown
Chan and Tipoe BMC Medical Ethics 2013, 14:43
http://www.biomedcentral.com/1472-6939/14/43DEBATE Open AccessThe policy statement of the American academy of
pediatrics – children as hematopoietic stem cell
donors – a proposal of modifications for
application in the UK
Tak Kwong Chan1* and George Lim Tipoe2Abstract
Background: With a view to addressing the moral concerns about the use of donor siblings, the Policy Statement
of the American Academy of Pediatrics - Children as Hematopoietic Stem Cell Donors (the Policy) has laid out the
criteria upon which tissue harvest from a minor would be permissible.
Discussion: Although tissue harvest serves the best interests of recipient siblings, parents are also obliged to act in
the best interests of the donor sibling in the UK. Tissue harvest should proceed if and only if it serves the best
interests of both the donor and recipient. Parents should be forbidden, and they are by UK law, to consent to
tissue harvest unless there are substantial benefits for an incompetent minor that can outweigh the potential harm.
There is no basis to subject a minor to the medical risks of tissue harvest if the recipient sibling can wait without
significant risks of complications until the donor becomes Gillick competent. We also argue that the Policy fails
to take into account recent advances in haematopoietic transplantation from haploidentical donors or related
tissue-matched donors.
Summary: Unless a recipient sibling will suffer from serious complications or die without the transplantation and
no other medically equivalent donors are available, there is no moral or legal basis to violate the donor sibling’s
right to bodily integrity. Accordingly, we propose that the Policy should be modified in order to fully satisfy the
legal requirements for application in the UK and other commonwealth jurisdictions with similar statute laws
protecting minors.
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In conjunction with preimplantation genetic diagnosis
(PGD), assisted reproduction can be used to avoid inher-
itable diseases. After successful in-vitro fertilization,
PGD can identify whether any of the embryos is affected
by a genetic condition. Parents now can even request se-
lection of embryos on the basis of tissue type in order to
create a child to cure an existing sick child. In response
to the moral concerns about the use of paediatric haem-
atopoietic cell donor siblings (donor siblings), the Policy* Correspondence: theo@hku.hk
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reproduction in any medium, provided the orStatement of the American Academy of Pediatrics –
Children as Hematopoietic Stem Cell Donors (the Policy)
suggests that tissue harvest should only proceed upon
satisfaction of all the following five criteria:
1) there is no medically equivalent histo-compatible
adult relative who is willing and able to donate;
2) there is a strong personal and emotionally positive
relationship between the donor and recipient;
3) there is some likelihood that the recipient will
benefit from the transplantation;
4) the clinical, emotional, and psychosocial risks to the
donor are minimized and are reasonable in relationtral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to the recipient; and
5) parental permission and, where appropriate, child
assent have been obtained’ [1].
Except that the fourth criterion requires the physician to
minimise the risks of medical procedures by, e.g. avoiding
central venous catheter insertion and reducing psycho-
logical risk by proper communication skills and the fifth
requires that child assent should be obtained where appro-
priate, the remaining criteria seem to merely state the facts
common to most cases of tissue harvest rather than regu-
lating the process. We contend that the Policy fails to suf-
ficiently protect the interests of minor donors. In this
article we would like to review the prevailing UK law, dis-
cuss the ethical relevance, and propose modifications of
the Policy for application in the UK and other common-
wealth jurisdictions with similar statute laws.
Discussion
The legal principles
One would not dispute that tissue harvest serves the best
interests of recipient siblings. But we are also obliged to
look at the welfare of the donor sibling. In Birmingham
City Council v H (a minor), Balcombe LJ said the question
of welfare of both children should be approached ‘without
giving one priority over the other’ [2]. In the UK, any
persons beyond the age of 16 can consent to medical
treatment. Where a child is below the age of 16, as estab-
lished in the case of Gillick, a child could consent if he or
she fully understands the medical treatment that is pro-
posed (i.e. Gillick competent) [3]. In case a donor sibling
has not yet achieved sufficient understanding and intel-
ligence to fully understand the proposed transplantation,
the Children Act 1989 requires that a parent must act in
the best interests of the donor [4]. In Re C (HIV Test), the
parents of a baby born to a HIV positive mother opposed
the testing of the child for HIV. Wilson J stated that the
views of the parents were important factors in the decision
but that “the baby had rights of her own recognised in
national and international law, the baby’s welfare was
paramount, and in the baby’s interests the test should take
place” [5]. The assessment of best interests is a balance
of the benefits and risks of transplantation for the
donor. The procedures need not be risk free but parents
should only consent to tissue harvest if the possible
benefits for the donor outweigh the potential harm.
Furthermore, if a person under the age of 18 refuses to
consent to a treatment, it is possible for their parents to
overrule their decision. However, this right can be exer-
cised only for the welfare of a child, and in the case of
tissue transplantation, the Children Act 1989 empowers
the court to intervene if parents fail to act in the best
interests of the donor sibling [4,6].The best interests of donor siblings
Well-documented risks
The most ethically sound basis to oppose tissue harvest
is that it imposes risks of bodily injuries associated with
the medical procedures of tissue harvest. The risks de-
pend on the source of cells namely bone marrow, per-
ipheral blood and umbilical cord blood, each with their
own benefits and risks. It is known that harvest by um-
bilical cord blood carries no medical risks except in case
of modified delivery. Therefore our analysis below fo-
cuses on bone marrow and peripheral blood transplant-
ation only. Minor complications like pain at collection
sites, fatigue and pain may occur in a small proportion
of donors (6%-20%). Major and life-threatening com-
plications following marrow donation like anesthesia-
related events, injuries to bones, sacroiliac joint and
sciatic nerve were estimated to occur in 0.1%-0.3% of
cases [7]. Major risks of peripheral blood transplantation
are mainly associated with sedation, general anaesthesia
and central venous catheter insertion, estimated to be
about 1.1% of cases [8]. In light of one’s inviolable right
to bodily integrity, minors should not be exposed to the
medical risks unless there are well-established benefits
of a significant magnitude that they can accrue from
tissue harvest.
Potential benefits
The possible benefits for donor siblings are merely psy-
chosocial. In an American case Curran v. Bosze, Calvo J
said that ‘the psychological benefit is grounded firmly in
the fact that the donor and the recipient are known to
each other in a family. There may be a psychological
benefit to the child from donating bone marrow to a
sibling’ [9]. We consider that tissue harvest can have
short-term and long-term psychosocial effects for donor
siblings. When presented with the idea of donation,
younger donors were found to focus more on the immedi-
ate pain and the frightening experience of the procedure
[10], whereas older children might feel pressure from fam-
ily members or medical staff to become a donor [11].
MacLeod and others found that about a third of the sib-
lings donors thought that doctors and family members
limited their opportunity to say no, making them perceive
they had a ‘forced no choice’ [10]. And donor siblings re-
ported higher levels of anxiety and lower self-esteem than
non-donor siblings [12], which may be attributed to the
lack of choice in the decision to donate. It follows that a
donor sibling is more likely to have short-term psycho-
social burdens rather than benefits.
Long term positive effects for the donor siblings in-
clude greater sensitivity to the needs of others [13],
enhanced self-sufficiency and independence [14], in-
creased family closeness [15], and most important of all,
the possible companion of a healthy recipient sibling.
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when their recipient siblings developed long-lasting
complications from the procedure. Furthermore, anger,
guilt, and blame were common amongst donor siblings
with unsuccessful transplant [10]. While the Policy cited
the findings of three studies that all donor siblings
agreed that the psychosocial benefits and harm of serv-
ing as a donor outweighed the physical harms, Macleod,
Wieners and others found that only 66.6% and 67% of
donor siblings reported a predominantly positive psy-
chosocial experience [10,16]. Importantly, all reporting
predominantly positive psychosocial experience had suc-
cessful transplant and only donors with unsuccessful
transplant reported a predominantly negative experience
in Macleod’s study [10]. Chang and others also showed
that donors for recipients who die remain significantly
more depressed than donors for recipients who survive 6
months after donation [17]. As the psychosocial expe-
rience is highly associated with the outcome for the reci-
pient, we contend that the long-term benefits for donor
siblings more likely derive from the survival of the recipi-
ent sibling rather than from process of tissue harvest itself.
Balance of benefits and risks
Whereas the advantages of tissue harvest for donor sib-
lings are long-term and merely psychosocial, the other
side of balance sheet consists of short-term psycho-
logical burden and life-threatening physical harm. One
should bear in mind that the notion of benefits and risks
are both relative concepts. To consider the potential
gains or losses for donor siblings, we ought to consider
what would likely happen to the donors and recipients
without tissue harvest. It cannot be said that tissue har-
vest can offer any significant long-term benefits for the
donor sibling if other available source of transplant can
offer a similar chance of success or if the sick sibling has
a high chance of survival without serious complications
even without transplantation. Those who do not agree
may argue that a donor sibling may in the future relish
and take pride in being a donor and therefore still want
to donate even if other donors are available.
Parents may legitimately consider this factor when
making decisions for incompetent minors. However, the
sense of pride may not materialize if the grown-up
donor sibling does not accept the filial or social respon-
sibility to save the recipient sibling, is disinterested in
altruistic donation, or does not relish in living in the
shadows of the recipient sibling. It is too speculative to
suggest that an autonomous individual would necessarily
prize the honour of ‘a donor and saviour’ above all
things if there are other suitable donors willing to
donate or if the recipient is not in the most dire need of
transplantation. As the Policy permits transplantation
only if there is no medically equivalent histo-compatibleadult relative who is willing and able to donate, it is be-
yond dispute that a moral agent should not subject a
minor to the risks of tissue harvest if there are other
equally good alternatives. It implies that the sense of
pride alone is not an overriding factor in assessing the
benefits and for a minor donor. In short, the only cir-
cumstance where tissue harvest would likely serve the
best interests of a minor donor is that without the pro-
posed transplantation taking place, the sick sibling will
have a high chance of dying or suffering from serious
complications.
The ethical basis of the legal approach
We hold that the above legal approach is in line with the
Beauchamp and Childress’ principled-based approach of
ethical analysis [18]. As one does not have a legitimate
claim to life to such an extent that it unjustly causes
harm to another person, [19] the principles of benefi-
cence, non-maleficence, and justice demand that parents
should consent to tissue harvest only if it serves the best
interests of both the donor and recipient.
Huge benefits v minimal risks
In response, one may argue that the requirement that a
sick sibling will suffer serious complications or die with-
out the proposed transplantation is too high a bar. How-
ever, as we have illustrated in the legal analysis above,
unless this requirement is satisfied, the donor sibling is
unlikely to benefit from the tissue harvest. Month said ‘I
do not believe that a day of minor discomfort and an
extremely small risk of anesthesia outweigh a lifetime
without a healthy older brother or sister and the years of
joy it potentially brings’ [20]. It is tempting but errone-
ous to balance the benefits for the sick sibling rather
than those for the donor against the medical risks of
transplantation for the donor. The rationale that min-
imal bodily invasion with low risks is a justification is
also seriously flawed as it is not the degree of the risks
of a medical procedure but the bodily invasion itself that
matters. The right to have intact bodily integrity is a
matter of the right to privacy irrespective of the degree of
invasion [21]. If such invasion is not allowed for adults
without their consent, there is no basis to allow this for
children [22]. So the benefits must be so substantial for
the donor that it relates to the survival of the sick sibling
with a view to justifying the risk of transplantation.
Conflict of interests
One may then question the validity of the claim that
transplantation can proceed only if it also serves the best
interests of the donor sibling. Beauchamp and Childress
gave little guidance regarding the approach of resolving
conflicts of interests between two persons. But it is gen-
erally accepted that when there are conflicts between
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violation. As the UK court has previously held, pursuant
to prevailing family law principles, it was bound to make
the least detrimental choice [23].
Transplantation will not benefit the donor sibling, as
we contend above, when there is another source of med-
ically equivalent tissue from a mentally competent adult
or when the sick sibling will not die or suffer from ser-
ious complications without the transplantation. In the
former case, to minimize the effect of violation of auton-
omy, we should accept donation from a competent adult
who agrees to donate rather than harvest tissue from a
minor who cannot consent. In the latter, as the sick sibling
can still survive in an acceptably healthy condition even
without transplantation, the least detrimental choice is to
wait until the donor can understand the process of trans-
plantation (i.e. Gillick competent) and decide whether he
would like to agree to altruistic donation.
Familial duties
Lastly, one may argue that there is a special duty to rescue
a sick sibling as a result of a family relationship. Dwyer
and Vig held that a donation is justifiable even if it does
not benefit the donor sibling, so long as there is ‘a moral
match between the relationship and the risks to the donor
relative to the benefits to the recipient’ [24]. But putting
the entire situation in the context of a family hardly ad-
vances an argument in favour of tissue harvest in case the
best interests of the donor are not served. Members within
a family usually have different relationships with one
another complicated with different interests, rights and
obligations. While a parent might feel obliged to donate to
a child, a sibling may not necessarily feel the same.
We submit that it is only fair to impose an obligation
to a member of any units or organisations under one of
the two following conditions. First, it is considered that
the interests of the unit or organisation prevail over the
interests of any individual member. Nonetheless, the in-
fringement of a member’s rights as a result of such an
imposition of duty must be the least possible infringe-
ment without which the primary goal commensurate
with the resulting infringement cannot be achieved. In
the case of tissue harvest from a donor sibling, this con-
dition will be satisfied only if other sources of medically
equivalent tissue from a mentally competent adult are
not available. Further, it will not be otherwise propor-
tionate to violate the donor’s bodily integrity unless the
recipient sibling has a high chance of dying or suffering
from serious complications without transplantation.
Second, an individual agrees, either by word or by con-
duct, to abide by a set of norms or regulations that im-
pose such an obligation while entitling him to certain
privileges. In the circumstance, it cannot be legitimate
to impose parents’ view of familial obligations on a childwho is not yet able to appreciate his rights and obliga-
tions in the family [21]. In fact, if the first condition is
satisfied, transplantation will also serve the best in-
terests of the donor sibling and there will be no need to
invoke the concept of familial duties to justify tissue
harvest.
Availability of other donors
In light of foregoing discussion, to determine whether
tissue harvest can be legally and ethically permitted, one
should assess first whether the recipient sibling would
have a high chance of dying or suffering from serious
complications without a transplantation. If the answer is
affirmative, then one should see if donation from any
mentally competent donors can offer a similar chance of
successful transplantation.
In the past, tissue-matched related donors were consid-
ered to be the best sources of donation. But now, many
drawbacks of unrelated or haplo-identical transplants such
as graft failure and significant graft-versus-host diseases
have been overcome due to the development of new
extensive T-cell depletion techniques with mega dose
stem cell administration over the last two decades. New
approaches such as alloreactive T cell depletion and post-
transplant cell therapy have also improved immune recon-
stitution in tissue-matched unrelated or haplo-identical
transplants. Using haplo-identical donors are now consid-
ered to be equally safe and effective transplant strategies as
tissue-matched donors for advanced leukemia [25]. Leung
and others showed that the five year survival rates of reci-
pient siblings with high risk leukemia are promising re-
gardless of donor types (68% for donor siblings, 74% for
unrelated donors and 77% for haplo-identical donors), and
that the risks of death from graft-versus-host diseases at five
years is not significantly associated with the types of donors
(6.6% for donor siblings, 7.0% for unrelated donors, and
3.4% for haplo-identical donors) [26]. Saber and others also
showed that for adult patients with acute myeloblastic
leukemia, transplantation from tissue-matched unrelated
donors and tissue matched related donors do not differ in
terms of 3-year survival, relapse and cumulative incidences
of chronic graft-versus-host diseases three years after trans-
plantation [27]. Therefore, a search for competent family
members, local and even international bone marrow donor
registry should be undertaken before parents are permitted
to consent to tissue harvest from donor siblings for recipi-
ents suffering from advanced lymphoma or leukemia. For
other diseases, Sodani and others reported that haplo-
identical transplant in thalassemia has 93% chance of
survival and only 7% mortality using new conditioning regi-
men [28]. Bolaños-Meade and others showed that the use
of haplo-identical transplant for patients with sickle cell
disease is highly effective and safe despite the fact that graft
failure still remains an obstacle [29].
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It is already well established that the use of haplo-identical
transplant is equally safe and effective for advanced
lymphoma or leukemia, whereas studies are still underway
to evaluate the results with non-malignant diseases like
aplastic anemia, lupus and sickle cell diseases. The above
literature search by no means suggests that haplo-identical
transplant can replace tissue-matched transplant but,
given the success of new regimens of transplantation, doc-
tors should look beyond the availability of tissue-matched
related donors for certain types of diseases. Parents and
doctors should make sure, if the medical conditions of the
sick sibling permit a search, that no other sources of
equally or similarly effective transplant are available before
subjecting a minor to the physical risks and short-term
psychological harm of tissue harvest.
In the circumstances, we propose that the following
should replace the original first, third, and fifth criteria
in the Policy:
1. If the medical conditions of the recipient permit a
search, there is no medically equivalent haplo-
identical/histo-compatible related adult or histo-
compatible unrelated adult who is willing and able
to donate;
3. The recipient sibling will have a high chance of
dying or suffering from serious complications
without transplantation before the donor sibling
becomes Gillick competent;
5. Parental permission is obtained if the donor sibling
is not Gillick competent.Summary
The parental choice to harvest tissues from donor siblings
reflects the immense ‘emotive desire to do something to
help the recipient sibling’ [30]. However, donor siblings
may not necessarily reap any benefits in light of the risks
of serious injuries arising from bone marrow or peripheral
blood transplantation. Fulfilling the criteria specified in
the Policy of the Academy alone is not sufficient to justify
tissue harvest from minors. Unless a recipient sibling will
likely suffer from serious complications or die without the
transplantation and no tissue-matched unrelated donors
or related haploidentical donors are available, there is no
moral or legal basis to violate the donor sibling’s right to
bodily integrity. In short, to apply the Policy in the UK or
other commonwealth jurisdictions with similar statutes, it
should be revised to fully comply with the law and address
our moral concerns in relation to tissue harvest from
minor donor siblings.Competing interests
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